Browse studies

Find your next paid study

79 recruiting studies matching your filters

The Feasibility of Steady State CBV Mapping Using Ferumoxytol Immediately After Gadolinium Enhanced MRI of the CNS

This phase II trial studies how well gadolinium and ferumoxytol magnetic resonance imaging (MRI) work in diagnosing patients with abnormalities in the central …

Central Nervous System NeoplasmCranial Nerve DisorderMetastatic Malignant Neoplasm in the Brain

Estimated

~$10 – $7,500

OHSU Knight Cancer InstituteNCT03270059

Multi-Institution Registry of SRS/SBRT Procedures

The RSSearch® Registry is an international multi-year database designed to track SRS/SBRT (Stereotactic Radiosurgery/Stereotactic Body Radiation Therapy) utili…

NeoplasmsArteriovenous Malformation of Central Nervous SystemTrigeminal Neuralgia

Estimated

~$10 – $1,125

The Radiosurgery SocietyNCT01885299

Prospective Data Registry and Quality of Life Assessment of PatientsUndergoing Radiotherapy With the RefleXion Medical Radiotherapy System (PREMIER Registry)

The purpose of this prospective cohort study is to assess clinical and quality of life measures as well as to define the severity of adverse effects for the us…

CancerCancer Central Nervous SystemCancer Thoracic+5 more

Estimated

~$10 – $1,125

RefleXion MedicalNCT05406167

Phase 1

A Phase Ib/II Study of Pembrolizumab, Ibrutinib and Rituximab in Refractory/Relapsed Primary Central Nervous System Lymphoma (PCNSL)

This research study is evaluating a combination therapy of 3 drugs as possible treatments for recurrent primary central nervous system lymphoma (PCNSL). The t…

Primary Central Nervous System LymphomaRecurrent CancerRefractory Cancer+1 more

Estimated

~$10 – $7,500

Dana-Farber Cancer InstituteNCT04421560

Phase 1

A Pilot Study of Pembrolizumab in Combination With Chemotherapy in Newly Diagnosed Primary Central Nervous System Lymphoma

This research study is studying if the investigational drug, Pembrolizumab, in combination with chemotherapy helps primary central nervous system lymphoma with…

LymphomaPrimary Central Nervous System Lymphoma

Estimated

~$10 – $7,500

Dana-Farber Cancer InstituteNCT06475235

Phase 1

A Phase 1b Study of Glofitamab in CNS Lymphoma

This phase Ib trial tests the safety and side effects of glofitamab after pre-treatment with obinutuzumab and how well they work in treating patients with cent…

Primary Central Nervous System LymphomaSecondary Central Nervous System Lymphoma

Estimated

~$10 – $6,250

City of Hope Medical CenterNCT06922604

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical tria…

Cancer, MetastaticCancerCancer of Pancreas+40 more

Estimated

~$10 – $1,050

Massive Bio, Inc.